May 1, 2025
TOPLINE: An analysis of data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database revealed differences in patterns of ocular events associated […]
April 28, 2025
TOPLINE: In some children with myopia, repeated low-level red-light therapy for at least 1 year was associated with reduced cone density near the fovea and other […]
April 22, 2025
TOPLINE: Current smokers faced up to 12-fold higher risk for age-related macular degeneration, a threefold higher risk for primary open-angle glaucoma, and a fourfold higher risk […]
April 16, 2025
Two consultants from Moorfields Eye Hospital in London restored vision for 24 young men in Bangladesh during a humanitarian mission earlier this year. The patients had […]
April 4, 2025
TOPLINE: Children with early-onset atopic dermatitis (AD) were nearly twice as likely to develop pediatric uveitis as were those without the condition. The elevated risk was […]
April 3, 2025
(Reuters) – The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, the company said on Thursday, […]
April 3, 2025
The sponsor of two phase 3 clinical trials of an add-on agent to treat age-related macular degeneration has decided to halt both trials after they showed […]
March 28, 2025
An eye drop formulation intended to slow progression of myopia in children has been recommended for a marketing authorization by the European Medicines Agency (EMA). Ryjunea, […]
March 28, 2025
TOPLINE: The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those […]